Abstract
1 Fifty-two patients who had been treated for essential hypertension for at least 5 years with once-a-day pindolol alone or in combination with a diuretic participated in a strenuous exercise programme. The 24 h antihypertensive efficacy of once-a-day pindolol was shown in blood pressure readings made before the intake of the day's dose. 2 During the first stage of the study before interruption of therapy, pindolol maintained effective blood pressure control and prevented an excessive rise in blood pressure and heart rate following strenuous exercise. 3 Following a 6 week period of interruption of pindolol therapy, higher blood pressure and heart rate levels were reached following exercise. 4 After reintroduction of a single dose of pindolol, improvement in blood pressure control and lower heart rate levels were again seen following exercise. 5 Compared with the period without drug systolic and diastolic blood pressures were lowered to about the same extent at rest and during exercise after maintenance pindolol and after a single dose of pindolol following a 6 week interruption period, but pre-exercise levels rose considerably during the period when therapy was discontinued.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aellig W. H. beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers. Br J Clin Pharmacol. 1976 Apr;3(2):251–257. doi: 10.1111/j.1365-2125.1976.tb00600.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ahlquist R. P. Present state of alpha and beta adrenergic drugs III. Beta blocking agents. Am Heart J. 1977 Jan;93(1):117–120. doi: 10.1016/s0002-8703(77)80180-4. [DOI] [PubMed] [Google Scholar]
- Brecht H. M., Banthien F., Ernst W., Schoeppe W. Increased plasma noradrenaline concentrations in essential hypertension and their decrease after long-term treatment with a beta-receptor-blocking agent (prindolol). Clin Sci Mol Med Suppl. 1976 Dec;3:485S–488S. doi: 10.1042/cs051485s. [DOI] [PubMed] [Google Scholar]
- Collins I. S., King I. W. Pindolol, (Visken, LB46). A new treatment for hypertension: report of a multicentric open study. Curr Ther Res Clin Exp. 1972 Apr;14(4):185–194. [PubMed] [Google Scholar]
- Crowder D., Cameron E. G. A multi-centre general practice trial of a pindolol/clopamide combination ('Viskaldix') in essential hypertension. Curr Med Res Opin. 1979;6(5):342–350. doi: 10.1185/03007997909109449. [DOI] [PubMed] [Google Scholar]
- Davies D. J. An assessment of pindolol in the general practice management of hypertension. Br J Clin Pract. 1976 Oct;30(10):200–201. [PubMed] [Google Scholar]
- Dhatariya R. C. Antihypertensive effects of pindolol in patients on diuretics. Practitioner. 1977 Apr;218(1306):570–572. [PubMed] [Google Scholar]
- Dhatariya R. C., Blowers A. J. Once daily administration of pindolol in the treatment of hypertension. J Int Med Res. 1977;5(6):465–469. doi: 10.1177/030006057300100215. [DOI] [PubMed] [Google Scholar]
- Hill R. C., Turner P. Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man. Br J Pharmacol. 1969 Jun;36(2):368–372. doi: 10.1111/j.1476-5381.1969.tb09511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Persson I. The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix). Eur J Clin Pharmacol. 1977 Jul 19;11(6):419–421. doi: 10.1007/BF00562931. [DOI] [PubMed] [Google Scholar]
- Prichard B. N. The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future. Br J Clin Pharmacol. 1978 May;5(5):379–399. doi: 10.1111/j.1365-2125.1978.tb01644.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reiterer W. Effects of long-term treatment with a beta-receptor blocker, pindolol, combined with a diuretic agent, clopamide, on exercise performance in hypertension. Curr Med Res Opin. 1980;6(8):552–558. doi: 10.1185/03007998009109486. [DOI] [PubMed] [Google Scholar]